top
TransMedics Director David Weill Purchases $109,000 of Stock -- Should Investors Buy Too?
Archived — last updated
Director David Weill purchased 1,336 shares of TransMedics Group on September 11, 2026. The transaction was disclosed in a regulatory filing and carried a weighted average price of 81 dollars and 63 cents per share.
Latest updates
No updates on this story yet.
AI-assisted summary of the reporting above. Quotes are kept to one sentence. Copyright concern? See our DMCA takedown page.